Wearable Injectors Market Trend - Increasing Prevalence of Chronic Diseases Across the Globe

Increasing prevalence of chronic diseases across the globe, growing awareness about wearable injectors, and rising focus on developing advanced products are expected to drive global market growth  

According to Emergen Research, the global wearable injectors market size was USD 6.75 billion in 2020 and is expected to reach USD 15.66 billion in 2028 and register a steady CAGR of 11.2% during the forecast period, 2021-2028.

Market Dynamics:

Wearable injectors are drug delivery systems that adhere to the body and automatically administrate set doses at specific times.  These wearable injectors are single-use systems that can be conformably worn on the body while the drug is delivered subcutaneously over a pre-programmed period. Most of these wearable injectors are capable of storing large volumes of drugs and aid in tracking and managing doses to avoid double injections or missed injections. These devices enable patients to perform their daily routine activities seamlessly while receiving the medication continuously and comfortably.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/543

Factors such as increasing prevalence of chronic diseases such as cardiovascular diseases, diabetes, and cancer, rising geriatric population across the globe, ongoing research on self-injectable systems, and high preference for wearable injectors due to fear of needles, risk of stick-needle injuries are expected to drive global market revenue growth during the forecast period.

In addition, increasing focus on developing advanced, user-friendly, and cost-effective devices and high preference for homecare settings are expected to fuel market growth going ahead. However, low awareness about advanced wearable injector systems in many developing countries, high costs of certain wearable injectors, and high preference for alternative drug delivery methods are some factors that can hamper overall market growth to a certain extent during the forecast period.

COVID-19 Impact Analysis 

  • Social distancing and restrictions severely disrupted businesses and operations
  • Lockdowns caused disruptions in transportation and logistics
  • Impacted manufacturing activities and mining operations globally
  • Took a toll on economy of various countries
  • Caused sudden and drastic downturn in economic activity
  • Disrupted agriculture, fisheries, dairy, and other sectors
  • Caused loss of employment and financial crisis
  • Supply impacts were further compounded owing to reduced disposable income
  • Emergence of variants continue to cause concerns and impact normal routines

Diabetes Segment To Register Rapid Revenue Growth: 

The diabetes segment is expected to register rapid revenue growth during the forecast period. This can be attributed to increasing prevalence of diabetes across the globe, rising elderly population, rapid advancements in wearable injectors, and growing demand for advanced wearable injectors to track and manage diabetes therapy in homecare settings. 

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/543

Homecare Segment to Account for Largest Revenue Share:

The homecare segment is expected to account for largest revenue share during the forecast period owing to increasing geriatric population, large patient pool, rising preference for therapy in home environment, and high focus on developing advanced and cost-effective self-injections for homecare settings. 

North America to Lead In Terms of Revenue Share:

North America is expected to dominate other regional markets in terms of revenue share during the forecast period owing to increasing prevalence of cardiovascular diseases, diabetes, and cancer across the region, rapid adoption of advanced technology, and growing inclination towards pain-free drug administration. In addition, presence of leading companies, rising geriatric population, and increasing adoption of homecare settings are expected to drive North America market growth going ahead.    

Major Companies in the Market Include:

  • Medtronic
  • Amgen
  • Ypsomed
  • Insulet Corporation
  • West Pharmaceutical Services
  • Becton, Dickinson And Company
  • Enable Injections
  • United Therapeutics Corporation
  • F. Hoffmann-La Roche AG
  • Johnson & Johnson

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/wearable-injectors-market

Scope of Wearable Injectors Research

Report Details


Market size in 2020

USD 6.75 Billion

CAGR (2021–2028)


Revenue forecast in 2028

USD 15.66 Billion

Base year for estimation


Historical data


Forecast period


Quantitative units

Revenue in USD Billion, Revenue share (%), and CAGR (%)

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Technology, Type, Application, End-use, and Region

Regional scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country scope

U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, South Africa

Key companies profiled

Medtronic, Amgen, Ypsomed, Insulet Corporation, West Pharmaceutical Services, Becton, Dickinson And Company, Enable Injections, United Therapeutics Corporation, F. Hoffmann-La Roche AG, and Johnson & Johnson

Customization scope

10 hours of free customization and expert consultation


For the purpose of this report, Emergen Research has segmented the global wearable injectors market on the basis of technology, type, application, end-use, and region:

Technology Outlook (Revenue, USD Billion; 2018–2028)

  • Motor-driven
  • Expanding Battery
  • Spring-based
  • Rotary Pump
  • Others

Type Outlook (Revenue, USD Billion; 2018–2028)

  • Off-body
  • On-body

Application Outlook (Revenue, USD Billion; 2018–2028)

  • Cardiovascular Disease
  • Diabetes
  • Immuno-Oncology
  • Infectious Diseases
  • Others

End-use Outlook (Revenue, USD Billion; 2018–2028)

  • Clinics
  • Hospitals
  • Home Care Settings
  • Others

Custom Requirements can be requested for this Report [Customization Available] @ https://www.emergenresearch.com/request-for-customization/543

Regional Outlook (Revenue, USD Billion; 2018–2028)

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • Saudi Arabia
    • U.A.E.
    • South Africa
    • Turkey
    • Rest of MEA

Related Published Articles Published by Emergen Research:

Feminine Hygiene Products Market

3D Food Printing Market

Electrosurgical Devices Market

Ammunition Market

Small Arms Market

Photoacoustic Imaging Market

Surface Treatment Chemicals Market

Insulation Materials Market

PVDF Membrane Market

Industrial Maintenance Coatings Market

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend’s existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Emergen Research Media Citations: https://www.emergenresearch.com/media-citations

Visit for More Insights: https://www.emergenresearch.com/insights

Explore Our Custom Intelligence services | Growth Consulting Services

Press Release Available https://www.emergenresearch.com/press-release/global-wearable-injectors-market

Back to news